# Atonarp

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/atonarp

- Industry: Industrial Machinery
- Headquarters: Tokyo, Japan
- Website: www.atonarp.com
- Total disclosed funding: $91M
- Latest round: Series D (May 18, 2021)
- Investors on record: 11

## About

Based in Japan, Atonarp Inc. specializes in advanced molecular metrology solutions, providing innovative platforms for mass spectrometry and optical spectrometry in various industries, particularly semiconductor and pharmaceutical sectors.Founded in 2009 in Tokyo, Japan, Atonarp Inc. is dedicated to developing molecular measurement technologies. The company has not undergone significant pivots or changes in its business model. Tomo Sato and Tomoyoshi Sato, who have experience in technology development, co-founded Atonarp. The company raised a total of JPY 5,460.000 mn through its most recent funding round, Series D, led by Celesta Capital and other investors such as ATI Korea and Japan Post Investment Corporation, bringing its current valuation to JPY 24,739.360 mn.Atonarp specializes in advanced molecular metrology solutions primarily through its innovative platforms in mass spectrometry and multi-laser optical spectrometry. Their flagship products include ASTON, designed for semiconductor manufacturing and various industrial applications, and ASTON LyoSentinel, which focuses on lyophilization processes within the pharmaceutical and life sciences sectors. These systems operate in real-time to monitor chemical compositions and biological markers with high sensitivity and without contact with samples, enhancing throughput and reducing waste. Atonarp’s customers include semiconductor manufacturers, pharmaceutical companies, and research institutions globally, with significant markets in North America, Europe, and Asia. Their technology is utilized for various applications, including clinical diagnostics and industrial process control, catering to diverse end users from laboratories to production facilities.Atonarp's revenue model is primarily based on direct sales of its proprietary technologies and system solutions to business clients in the semiconductor and pharmaceutical industries. Transactions typically occur through B2B agreements, where clients procure products based on their specific requirements for in-situ molecular profiling and diagnostics. The company also engages in strategic partnerships that integrate its technologies into larger manufacturing processes or research frameworks. Their offerings, such as the ASTON and ASTON LyoSentinel systems, are crucial for clients requiring high-precision measurements in challenging environments. Although specific pricing plans are not disclosed, the revenue stream is sustained by the sale of both individual systems and ongoing service contracts to ensure optimal performance and support for their clients.Looking ahead, Atonarp plans to design and launch new products aimed at enhancing its molecular measurement capabilities, with specific release dates to be determined. The company is targeting expansion into new markets, particularly in regions such as Europe and Asia, by 2025. The recent funding round completed on December 27, 2024, will support these initiatives, allowing for increased investment in product development and market entry strategies.

## Funding rounds

- Series D, May 18, 2021, $50M — Japan Post Investment Corporation, Celesta Capital, Furukawa Electric Co., Ltd., Banner Industries, Boscolo Intervest, ATI Korea
- Series C, Aug 22, 2019, $33M — INCJ, SMBC Venture Capital, SBI Investment, Japan Post Investment Corporation, Future Ventures
- Series A, Jun 30, 2014, $7.9M — Walden Catalyst

## Investors

- Walden Catalyst (https://capitalatlas.ai/funds/walden-catalyst) — Series A
- INCJ — Series C
- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Series C
- SBI Investment (https://capitalatlas.ai/funds/sbi-investment) — Series C
- Japan Post Investment Corporation — Series C, Series D
- Future Ventures — Series C
- Celesta Capital (https://capitalatlas.ai/funds/celesta-capital) — Series D
- Furukawa Electric Co., Ltd. — Series D
- Banner Industries — Series D
- Boscolo Intervest — Series D
- ATI Korea — Series D